Prev Close | 194.98 |
Open | 195.23 |
Day Low/High | 190.74 / 195.47 |
52 Wk Low/High | 108.85 / 224.24 |
Volume | 722.20K |
Prev Close | 194.98 |
Open | 195.23 |
Day Low/High | 190.74 / 195.47 |
52 Wk Low/High | 108.85 / 224.24 |
Volume | 722.20K |
Exchange | NYSE |
Shares Outstanding | 145.51B |
Market Cap | 29.24B |
P/E Ratio | 46.25 |
Div & Yield | N.A. (N.A) |
The maker of ventilators and CPAP machines saw shares sell off in March but its technical signs still look good.
Here we go folks, a sampling of this morning's upgrades, downgrades and initiations. I'll be back with some thought on these after I get another cup of my morning fuel (coffee). Upgrades Sprint by UBS from Neutral to Buy with a $10 price target Res...
Here's how to play the stock now.
Let's check over the charts and indicators of ResMed.
Straying from these names could land you in quicksand as the 4th quarter begins.
Although equity index futures are lower, this whole thing has been taken in stride. For now.
A partial list of names that are showing signs of breaking out Monday.
Short-sellers are feeling the pressure this year, but you don't have to if you take a look at these four stock that could face short squeezes.
Shares of the maker of sleep-apnea devices are poised to rise and shine.
April report doesn't impress as averages have little to show.
Use stock lists as a source for trading ideas to pursue.
A positive report could help this maker of sleep-disorder products break out of its current consolidation.
These stocks have high short interest and could see some covering.
This name, which makes sleeping-disorder treatements, is a solid investment that should allow for some shut-eye.